Quotes Percheron Therapeutics Limited OTC Markets
Equities
ATHJF
AU0000317281
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.012 USD | -84.00% |
|
-.--% | +20.00% |
06-17 | Percheron Therapeutics Appoints CFO | MT |
06-03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
Performance
1 day | -84.00% | ||
3 months | +20.00% | ||
6 months | +20.00% | ||
Current year | +20.00% | ||
1 year | -76.00% | ||
3 years | -91.45% | ||
5 years | -64.18% | ||
10 years | -91.72% |
Volumes
marketsBasic data
Highs and lows
![Extreme 0.012](/images/extremecours_fleche.png)
![Extreme 0.01](/images/extremecours_fleche.png)
![Extreme 0.01](/images/extremecours_fleche.png)
![Extreme 0.01](/images/extremecours_fleche.png)
![Extreme 0.01](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-84.00% | -.--% | +20.00% | -76.00% | 48.02M | ||
+0.54% | -0.01% | +16.44% | +34.63% | 122B | ||
-1.17% | -2.48% | +18.94% | +45.39% | 113B | ||
+1.83% | -3.32% | +19.62% | +15.62% | 26.22B | ||
-0.09% | -6.66% | -25.37% | -27.03% | 19.01B | ||
-0.86% | -4.42% | -20.21% | -33.35% | 15.71B | ||
-0.66% | -4.68% | -20.20% | -19.28% | 15.22B | ||
-0.96% | -5.43% | -47.37% | -38.55% | 14.72B | ||
-1.63% | -2.44% | +59.91% | +34.65% | 14.58B | ||
-1.87% | +1.78% | +4.35% | +45.80% | 13.84B | ||
-2.77% | -7.47% | +108.13% | +205.69% | 10.4B | ||
-1.37% | +1.35% | +141.16% | +267.95% | 9.15B | ||
-2.78% | +2.80% | -25.64% | -35.19% | 8.16B | ||
-1.14% | +2.09% | +21.11% | +52.30% | 8.27B | ||
+1.71% | +0.35% | +8.19% | +52.68% | 7.82B | ||
-0.29% | +4.22% | -2.76% | +29.69% | 7.51B | ||
Average | -5.97% | -1.58% | +17.27% | +34.69% | ||
Weighted average by Cap. | -0.43% | -1.74% | +15.32% | +35.42% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +20.00% | ||
2023 | -84.62% | ||
2022 | -56.67% | ||
2021 | +47.49% | ||
2020 | +64.83% | ||
2019 | +208.50% | ||
2018 | -31.03% | ||
2017 | -.--% | ||
2016 | -56.06% | ||
2015 | -15.38% | ||
2014 | +680.00% | ||
2013 | +100.00% | ||
2012 | -66.67% | ||
2011 | -75.00% | ||
2009 | +50.00% | ||
2008 | -20.00% | ||
2007 | -.--% |
- Stock Market
- Equities
- PER Stock
- ATHJF Stock
- Quotes Percheron Therapeutics Limited